Autism Spectrum Disorder Trial, Recruiting (NCT07717853)

Autism Spectrum Disorder Trial, Recruiting NCT07717853 Sponsor: Atlas University Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT07717853 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People with a confirmed diagnosis of autism spectrum disorder
Children who are of primary school age
Children who have enough communication and cooperation skills to take part in a specific type of goal-focused therapy called the Cognitive Orientation to Daily Occupational Performance intervention
Children (and/or their family) who have identified at least one goal related to a daily activity they want to improve
Children who are able to attend assessment and therapy sessions on a regular basis
Children whose parent or legal guardian has provided written consent to participate

Who may not be able to join:

Children with a serious neurological, physical, or psychiatric condition that could significantly affect their ability to take part in the assessment or therapy sessions
Children with severe behavioural difficulties that would make it unsafe or very difficult to consistently participate in the sessions
Children who have taken part in an intensive, structured program focused on cognitive strategies within the past 6 months
Children or families who choose to withdraw from the study after joining

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +905376699979

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07717853

Sponsor: Atlas University

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: +905376699979

More information: https://clinicaltrials.gov/study/NCT07717853

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People with a confirmed diagnosis of autism spectrum disorder
Children who are of primary school age
Children who have enough communication and cooperation skills to take part in a specific type of goal-focused therapy called the Cognitive Orientation to Daily Occupational Performance intervention
Children (and/or their family) who have identified at least one goal related to a daily activity they want to improve
Children who are able to attend assessment and therapy sessions on a regular basis
Children whose parent or legal guardian has provided written consent to participate

Who may not be able to join:

Children with a serious neurological, physical, or psychiatric condition that could significantly affect their ability to take part in the assessment or therapy sessions
Children with severe behavioural difficulties that would make it unsafe or very difficult to consistently participate in the sessions
Children who have taken part in an intensive, structured program focused on cognitive strategies within the past 6 months
Children or families who choose to withdraw from the study after joining

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Atlas University

Registry

ClinicalTrials.gov

Start date

10 July 2026

Est. completion

30 September 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Canadian Occupational Performance Measure; Performance Quality Rating Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov